Hemispherx (HEB) Reports Q4 Loss of $0.02/Share
Tweet
Share
E-mailGet Alerts HEB Hot Sheet
Price: $1.80 --0%
Financial Fact:
General and administrative: 1.64M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
General and administrative: 1.64M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Hemispherx Biopharma, Inc. (NYSE: HEB) reported Q4 EPS of ($0.02). Revenue for the quarter came in at $38 thousand.
For earnings history and earnings-related data on Hemispherx Biopharma, Inc. (HEB) click here.
For earnings history and earnings-related data on Hemispherx Biopharma, Inc. (HEB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
- Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
